Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  MUMBAI STOCK EXCHANGE  >  Dr. Reddy's Laboratories Limited    500124   INE089A01023

DR. REDDY'S LABORATORIES LIMITED

(500124)
  Report
SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsPress ReleasesOfficial PublicationsSector news

Indian shares rise as Dr.Reddy's boosts pharma stocks

share with twitter share with LinkedIn share with facebook
09/18/2020 | 01:08am EDT

BENGALURU, Sept 18 (Reuters) - Indian shares opened higher on Friday, boosted by pharma stocks after Dr.Reddy's Laboratories Ltd hit a record high, and as broader Asian markets advanced on hopes of more monetary support from central banks.

The blue-chip NSE Nifty 50 index rose 0.49% to 11,572.75 and the benchmark S&P BSE Sensex 0.44% to 39,151.72 by 0350 GMT. Both the indexes closed more than 0.7% lower in the previous session.

Dr.Reddy's rose as much as 4.1% to an all-time high and was among the top boosts to the Nifty 50 after the company settled a patent litigation with Bristol-Myers Squibb Co over cancer treatment Revlimid.

That helped the Nifty Pharma Index rise 2.67%.

Conglomerate Reliance Industries Ltd also helped boost the Nifty, gaining as much as 0.9%. (Reporting by Anuron Kumar Mitra in Bengaluru; editing by Uttaresh.V)


Stocks mentioned in the article
ChangeLast1st jan.
DR. REDDY'S LABORATORIES LIMITED -2.95% 4949.8 End-of-day quote.72.04%
NIFTY 50 -0.50% 11670.8 Delayed Quote.-2.29%
RELIANCE INDUSTRIES LTD 0.77% 2026.9 Delayed Quote.34.12%
SENSEX 30 -0.43% 39749.85 Real-time Quote.-3.23%
share with twitter share with LinkedIn share with facebook
All news about DR. REDDY'S LABORATORIES LIMITED
09:25aDR REDDY LABORATORIES : Outcome of Board Meeting
PU
02:20aDR REDDY LABORATORIES : . Reddy's partners with Department of Biotechnology - Bi..
BU
10/28DR REDDY LABORATORIES : India trials of Russian Sputnik-V vaccine may end as ear..
RE
10/28DR REDDY LABORATORIES : . Reddy's Names Parag Agarwal Chief Financial Officer
DJ
10/28DR REDDY LABORATORIES : Announces Appointment of New Chief Financial Officer
BU
10/28DOCTOR REDDY'S : Fiscal 2Q Earnings Snapshot
AQ
10/28DR REDDY LABORATORIES : . Reddy's Q2 & H1 FY21 Financial Results
BU
10/28DR REDDY LABORATORIES : 2Q Net Fell 30%
DJ
10/22Dr Reddy's isolates data center services after cyberattack
RE
10/22DR REDDY LABORATORIES : Data breach prompts India's Dr Reddy's to shut key plant..
RE
More news
Financials
Sales 2021 193 B 2 587 M 2 587 M
Net income 2021 27 365 M 368 M 368 M
Net cash 2021 9 881 M 133 M 133 M
P/E ratio 2021 30,6x
Yield 2021 0,52%
Capitalization 820 B 11 052 M 11 016 M
EV / Sales 2021 4,21x
EV / Sales 2022 3,66x
Nbr of Employees 21 650
Free-Float 69,0%
Chart DR. REDDY'S LABORATORIES LIMITED
Duration : Period :
Dr. Reddy's Laboratories Limited Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends DR. REDDY'S LABORATORIES LIMITED
Short TermMid-TermLong Term
TrendsBearishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 34
Average target price 5 307,09 INR
Last Close Price 4 949,80 INR
Spread / Highest target 30,3%
Spread / Average Target 7,22%
Spread / Lowest Target -25,2%
EPS Revisions
Managers
NameTitle
Erez Israeli Chief Executive & Operating Officer
Saumen Chakraborty President, CFO & Global Head-IT
Satish Kallam Reddy Co-Chairman
Gunupati Venkateswara Prasad Co-Chairman & Managing Director
Kalpana Jaisingh Morparia Independent Non-Executive Director
Sector and Competitors
1st jan.Capitalization (M$)
DR. REDDY'S LABORATORIES LIMITED72.04%11 068
JOHNSON & JOHNSON-5.15%364 239
ROCHE HOLDING AG-6.18%276 926
PFIZER INC.-9.52%196 991
MERCK & CO., INC.-16.24%192 678
NOVARTIS AG-21.82%179 655